Linagliptin - an inhibitor of dipeptidyl peptidase-4 (DPP-4) which prevent the hormone incretin from being degraded thus allowing the pancreas is stimulated to produce more insulin. It can potentially be used for the treatment of type 2 diabetes and may protect vascular health by reducing arterial stiffness.













